Severne Y, Coppens D, Bottari S, Riviere M, Kram R, Vauquelin G
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4637-41. doi: 10.1073/pnas.81.15.4637.
Only part of the beta-adrenergic receptors can undergo functional coupling to the adenylate cyclase regulatory unit. This receptor subpopulation shows an increased affinity for agonists in the presence of Mg2+ and undergoes rapid "inactivation" (locking-in of the agonist) by the alkylating reagent N-ethylmaleimide in the presence of agonists. Several experimental conditions, known to modify the total receptor concentration without alteration of the other components of the adenylate cyclase system, do not affect the percentage of receptors that can undergo functional coupling: (i) homologous regulation of beta 1 receptors in rat brain by noradrenaline (through antidepressive drug or reserpine injections); (ii) up- and down-regulation of the beta 2 receptors in Friend erythroleukemia cells by, respectively, sodium butyrate and cinnarizine treatment; and (iii) dithiothreitol-mediated inactivation of receptors in turkey erythrocytes, Friend erythroleukemia cells, and rat brain. Our findings argue against a stoichiometric limitation in the number of regulatory components, genetically different receptor subpopulations, bound guanine nucleotides, or reduced accessibility of part of the receptors to the agonists as the cause for functional receptor heterogeneity. Differences in either the receptor conformation or its membrane microenvironment are more plausible explanations.
只有部分β-肾上腺素能受体能够与腺苷酸环化酶调节单元进行功能偶联。在存在Mg2+的情况下,这一受体亚群对激动剂的亲和力会增加,并且在存在激动剂时会被烷基化试剂N-乙基马来酰亚胺快速“失活”(激动剂的锁定)。已知几种实验条件可改变总受体浓度而不改变腺苷酸环化酶系统的其他组分,但这些条件并不会影响能够进行功能偶联的受体百分比:(i)去甲肾上腺素对大鼠脑中β1受体的同源调节(通过注射抗抑郁药物或利血平);(ii)分别用丁酸钠和桂利嗪处理对Friend红白血病细胞中β2受体的上调和下调;以及(iii)二硫苏糖醇介导的火鸡红细胞、Friend红白血病细胞和大鼠脑中受体的失活。我们的研究结果反对将调节组分数量的化学计量限制、基因不同的受体亚群、结合的鸟嘌呤核苷酸或部分受体对激动剂的可及性降低作为功能性受体异质性的原因。受体构象或其膜微环境的差异是更合理的解释。